VISCHER advised EraCal on all legal issues related to the transaction. EraCal Therapeutics has signed a collaboration and license agreement with Danish pharma producer Novo Nordisk....
EraCal Therapeutics AG’s €235 Million Licensing Agreement To Novo Nordisk
Bachem’s CHF 583.5 Million Capital Increase
VISCHER AG advised Bachem Holding on the deal. Bachem Holding AG (SIX:BANB) has raised CHF 583.5m through an accelerated bookbuilding process by issuing 750,000 new shares...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...